Cerclage Outcome by the Type of Suture material (COTS) study

ISRCTN ISRCTN17866773
DOI https://doi.org/10.1186/ISRCTN17866773
Secondary identifying numbers N/A
Submission date
04/02/2013
Registration date
27/03/2013
Last edited
22/10/2018
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Pregnancy and Childbirth
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English Summary

Background and study aims
The COTS study addresses a research question which could potentially save the lives of more than 400 babies per year in the UK alone. These babies would otherwise die because of severe prematurity or early pregnancy loss. Undoubtedly, the improved outcome will have significant psychosocial benefits and health resource implications. Laxity (weakeness) of the neck of the womb (cervix) is one of the main causes of premature birth and early pregnancy loss for which a suture around the cervix (cerclage) has been used for many years. It is estimated that 6700 women will have a cerclage in the UK per year with varying success rates. Braided sutures have been traditionally used because they are deemed to be strong and easy to remove. However, braided non-dissolvable sutures have been consistently associated with increased risk of infection in most surgical procedures and are no longer used in eye and pelvic surgery for that reason. Infection is a major contributing factor to cerclage failure. Hence, some surgeons prefer to use monofilament non-braided sutures in cerclage. However, there is perceived concern about the degree of cervical support such sutures offer. We conducted a national survey of UK-based consultants Obstetricians & Gynaecologists which demonstrated that the majority of doctors were uncertain which is the best suture material for their patients. Therefore, COTS pilot study will provide the necessary information to confidently inform the need for a large national multi-centre study.

Who can participate?
All women (>17 years) with a singleton pregnancy and a valid indication for cervical cerclage:
-History of three or more previous mid trimester losses or premature (<28 weeks) births.
-Had cervical sutures in previous pregnancies
-History of mid-trimester loss or premature delivery with a shortened cervix on ultrasound scan (<25mm).
-Deemed at risk of preterm labour at the clinicians discretion (e.g. radical trachelectomy)

What does the study involve?
Eligible women will be randomly allocated to undergo cerclage either using a braided (standard) or non-braided (test material) suture between 14-20 weeks’ gestation. Apart from the type of suture material, participants will receive identical treatment. Outcomes to be measured are live birth rate, gestational age at birth, infection risk, mode and timing of delivery, length of hospital, any injuries to the cervix and neonatal unit stay.

What are the possible benefits and risks of participating?
There are no direct benefits to participants. The information we get from this study will help us to identify which suture is best to be used for the cerclage (stitch round the cervix) and is the best for prolongation of pregnancy.
There are no additional risks associated with taking part in this research. The risks of any cerclage are described below. Both stitches are commonly used and have theoretical advantage in preventing preterm labour or mid trimester loss. Inserting cervical stitch is a relatively common procedure. However, there are always risks to any surgical procedure. The uncommon risks (occurs in 1 out of 100-1000) include bleeding, infection and pain. It is usual to experience some period like tummy pain afterwards. We can give you some painkillers if necessary. You may also have some slight vaginal bleeding. This should stop within a few days. If you have increased vaginal discharge and your doctor worried about the infection, you may have vaginal swab taken. If there is evidence of infection you may be prescribed antibiotics.
There is no evidence that abstinence from sex following cerclage insertion has any impact on preterm delivery. It is also not routinely recommended to get a complete bed rest after the procedure. In a very small number of cases there is a technical difficulty with the procedure, so it may result in miscarriage or rupture of membranes. This is not, as far as we are aware, related to the suture material. The risk of premature delivery of the baby remains throughout the pregnancy (but this is the reason for the stitch).

Where is the study run from?
Several Units in Birmingham and one unit in Cambridge.

When is the study starting and how long is it expected to run for?
Study started in February 2013 and expected to run for 18 months.

Who is funding the study?
This pilot/feasibility study is funded by Urogynae Research Fund at Birmingham Women’s Hospital

Who is the main contact?
Mr Philip Toozs-Hobson
philip.toozs-hobson@bwhct.nhs.uk

Contact information

Mr Philip Toozs-Hobson
Scientific

Birmingham Women's Hospital
Mindilsohn Way
Birmingham
B5 2TG
United Kingdom

Phone +44 (0)121 627 4707
Email philip.toozs-hobson@bwhct.nhs.uk

Study information

Study designMulticentre pilot / feasibility randomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please contact Dr Fidan Israfil-Bayli, Birmingham Women’s Foundation Trust, 3rd floor, Edgbaston, Birmingham, B15 2TG to request a patient information sheet
Scientific titleA pilot/feasibility RCT comparing monofilament (intervention) versus multifilament (control) suture material for elective cervical cerclage in the management of suspected cervical incompetence
Study acronymCOTS
Study hypothesisCOTS will address the following research question:
Is it feasible to conduct a definitive randomised controlled trial (RCT) evaluating the therapeutic effectiveness of monofilament/non-braided suture material versus multifilament &/or braided suture material in improving pregnancy outcomes following cervical cerclage procedure?

The research hypothesis for COTS is based on the evidence showing that multifilament / braided non-absorbable sutures are associated with a higher risk of infection and hence have been abandoned in several surgical disciplines.
Ethics approval(s)West Midlands Research Ethics Committee, 11/06/2012, REC ref: 12/WM/0141
ConditionMidtrimester miscarriage or preterm birth due to cervical incompetence
InterventionCerclage can occur at any gestation between 14-20 weeks as long as it is performed as an elective procedure.The Monofilament non-braided suture used will be a looped Nylon and the Multifilament braided suture will be Mersilene tape for the intervention and control groups respectively. The stitch will be inserted using a McDonald technique. Planned removal of the suture would occur at 37 (+/-1 week) weeks’ gestation. When the stitch is removed it will be retained for microbiological investigations. A vaginal swab will be taken before the cerclage procedure to ensure that any infection is treated before inserting the suture. A vaginal swab will also be taken at the time of suture removal. The follow up should not involve additional contact with the patient beyond routine local clinical management protocols. Data required for all the proposed outcomes are significant objective outcomes in patient care and will be collected by notes review other than those required in the qualitative interviews. The study will be deemed complete when the last recruited woman has delivered and, if applicable, her baby is discharged from the neonatal unit.
Intervention typeOther
Primary outcome measureLive birth rate
Secondary outcome measures1. Gestation at delivery
2. Mode of delivery
3. Length of stay in neonatal unit
Overall study start date06/02/2013
Overall study end date08/02/2014

Eligibility

Participant type(s)Patient
Age groupAdult
SexFemale
Target number of participants100
Participant inclusion criteria1. All women (>17 years) with a singleton pregnancy and a valid indication for cervical cerclage, as per Royal College of Obstetricians and Gynaecologists (RCOG) guidance, as follows:
1.1. History of three or more previous mid trimester losses or premature (<28 weeks) births.
1.2. Had cervical sutures in previous pregnancies
1.3. History of mid-trimester loss or premature delivery with a shortened cervix on ultrasound scan (<25mm)
1.4. Deemed at risk of preterm labour at the clinicians discretion (e.g. radical trachelectomy)
Participant exclusion criteria1. Women who are unable or unwilling to give informed consent
2. Multiple pregnancy
3. Women under the age of 17 years
Recruitment start date06/02/2013
Recruitment end date08/02/2014

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Birmingham Women's Hospital
Birmingham
B5 2TG
United Kingdom

Sponsor information

Birmingham Women's Hospital (UK)
Hospital/treatment centre

Mindilsohn Way
BIrmingham
B5 2TG
England
United Kingdom

Phone +44 (0)121 627 4707
Email kelly.hard@bwhct.nhs.uk
Website http://bwhct.nhs.uk
ROR logo "ROR" https://ror.org/00xe5zs60

Funders

Funder type

Hospital/treatment centre

Birmingham Women's Hospital (UK) - Urogynaecology Research Fund

No information available

Birmingham Clinical Trials Unit (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol article protocol 27/10/2014 Yes No

Editorial Notes

22/10/2018: No publications found, verifying study status with principal investigator.